Skip to Main Content

Author Details

Ian L McAllister
University of Western Australia, Lions Eye Institute
1987
160
39
PMIDPaper TitleJournal TitlePublished Year
34340975Five-year outcomes of eyes initially enrolled in the 2-year BEVORDEX trial of bevacizumab or dexamethasone implants for diabetic macular oedema.Br J Ophthalmol2023
35508721Changes in 12-month outcomes over time for age-related macular degeneration, diabetic macular oedema and retinal vein occlusion.Eye (Lond)2023
35792359Longitudinal Analysis of Functional and Structural Outcome Measures in PRPH2-Associated Retinal Dystrophy.Ophthalmol Retina2023
37030494Benefits of a Laser Chorioretinal Anastomosis Plus Ranibizumab vs Ranibizumab Alone for Central Retinal Vein Occlusion: 4-Year Results.Am J Ophthalmol2023
36753186Inner Retinal Changes in Acute Experimental BRVO Treated With Bevacizumab or Triamcinolone Acetonide.Transl Vis Sci Technol2023
36692455Vessel Pulse Amplitude Mapping in Eyes With Central and Hemi Retinal Venous Occlusion.Transl Vis Sci Technol2023
36705252IMPACT OF RETINAL FLUID-FREE MONTHS ON OUTCOMES IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Treatment Agnostic Analysis of the HAWK and HARRIER Studies.Retina2023
36657697Endothelial contraction of retinal veins.Exp Eye Res2023
36371040Central Retinal Vein Occlusion 36-Month Outcomes with Anti-VEGF: The Fight Retinal Blindness! Registry.Ophthalmol Retina2023
35078771Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry.Br J Ophthalmol2023
33216649<i>Paracoccus yeei</i>, a Novel Bacterial Cause of Endophthalmitis following Intravitreal Injection.Ocul Immunol Inflamm2022
35344533SIBLING CONCORDANCE IN SYMPTOM ONSET AND ATROPHY GROWTH RATES IN STARGARDT DISEASE USING ULTRA-WIDEFIELD FUNDUS AUTOFLUORESCENCE.Retina2022
36474844Watch and wait for Rectal Cancer: A 9 year Experience.Ulster Med J2022
35869925One-year real-world outcomes of bevacizumab for the treatment of macular oedema secondary to retinal vein occlusion.Clin Exp Ophthalmol2022
33712484Twelve-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registry.Br J Ophthalmol2022
3451916712-month outcomes of ranibizumab versus aflibercept for macular oedema in central retinal vein occlusion: data from the FRB! registry.Acta Ophthalmol2022
33222283The effect of public opinion and politics on attitudes towards pill testing: Results from the 2019 Australian Election Study.Drug Alcohol Rev2021
36246008Atrophy Expansion Rates in Stargardt Disease Using Ultra-Widefield Fundus Autofluorescence.Ophthalmol Sci2021
33768164Functional benefits of a chorioretinal anastomosis at 2 years in eyes with a central retinal vein occlusion treated with ranibizumab compared with ranibizumab monotherapy.BMJ Open Ophthalmol2021
33939573Inherited retinal diseases are the most common cause of blindness in the working-age population in Australia.Ophthalmic Genet2021
34125082CLASSIFYING ABCA4 MUTATION SEVERITY USING AGE-DEPENDENT ULTRA-WIDEFIELD FUNDUS AUTOFLUORESCENCE-DERIVED TOTAL LESION SIZE.Retina2021
31619357Macular Atrophy in Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial Comparing Ranibizumab and Aflibercept (RIVAL Study).Ophthalmology2020
31872498Disabling glistenings in multifocal yellow chromophore intraocular lenses.Clin Exp Ophthalmol2020
31972799SURGICAL MANAGEMENT OF TRAUMATIC MACULAR HOLE: Optical Coherence Tomography Features and Outcomes.Retina2020
32974081Edge of Scotoma Sensitivity as a Microperimetry Clinical Trial End Point in <i>USH2A</i> Retinopathy.Transl Vis Sci Technol2020
32555630Real-world outcomes with ranibizumab in branch retinal vein occlusion: The prospective, global, LUMINOUS study.PLoS One2020
32501894Chorioretinal Anastomosis for Central Retinal Vein Occlusion: A Review of Its Development, Technique, Complications, and Role in Management.Asia Pac J Ophthalmol (Phila)2020
30502372Tolerating Subretinal Fluid in Neovascular Age-Related Macular Degeneration Treated with Ranibizumab Using a Treat-and-Extend Regimen: FLUID Study 24-Month Results.Ophthalmology2019
31014709Development of New Proliferative Diabetic Retinopathy in the BEVORDEX Trial.Ophthalmol Retina2019
30676617Effect of Ranibizumab and Aflibercept on Best-Corrected Visual Acuity in Treat-and-Extend for Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial.JAMA Ophthalmol2019
28842956Clinical and social characteristics associated with reduced visual acuity at presentation in Australian patients with neovascular age-related macular degeneration: a prospective study from a long-term observational data set. The Fight Retinal Blindness! Project.Clin Exp Ophthalmol2018
30193305Three-Dimensional Microscopy Demonstrates Series and Parallel Organization of Human Peripapillary Capillary Plexuses.Invest Ophthalmol Vis Sci2018
29803555Neuronal degeneration and associated alterations in cytokine and protein in an experimental branch retinal venous occlusion model.Exp Eye Res2018
31047526Outcomes of Eyes with Failed Primary Surgery for Idiopathic Macular Hole.Ophthalmol Retina2018
31047501Evaluating the Impact of Intravitreal Aflibercept on Diabetic Retinopathy Progression in the VIVID-DME and VISTA-DME Studies.Ophthalmol Retina2018
30347030Two-Year Efficacy of Ranibizumab Plus Laser-Induced Chorioretinal Anastomosis vs Ranibizumab Monotherapy for Central Retinal Vein Occlusion: A Randomized Clinical Trial.JAMA Ophthalmol2018
29448042Quantitative comparisons between optical coherence tomography angiography and matched histology in the human eye.Exp Eye Res2018
29470970Comparisons Between Histology and Optical Coherence Tomography Angiography of the Periarterial Capillary-Free Zone.Am J Ophthalmol2018
28715592Inter-Relationship of Arterial Supply to Human Retina, Choroid, and Optic Nerve Head Using Micro Perfusion and Labeling.Invest Ophthalmol Vis Sci2017
29167184Retrobulbar heavy liquid discovered 5 years postvitrectomy.BMJ Case Rep2017
26783096Bevacizumab or Dexamethasone Implants for DME: 2-year Results (The BEVORDEX Study).Ophthalmology2016
26537156Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial.Br J Ophthalmol2016
27698520Re-Staging Following Long-Course Chemoradiotherapy For Rectal Cancer: Does It Influence Management?Ulster Med J2016
27865764Phase 2a Randomized Clinical Trial: Safety and Post Hoc Analysis of Subretinal rAAV.sFLT-1 for Wet Age-related Macular Degeneration.EBioMedicine2016
27241461Assessment of polygenic effects links primary open-angle glaucoma and age-related macular degeneration.Sci Rep2016
27554034Treatment Patterns and Visual Outcomes during the Maintenance Phase of Treat-and-Extend Therapy for Age-Related Macular Degeneration.Ophthalmology2016
26994110Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration.Br J Ophthalmol2016
26991650TECHNIQUE OF LASER CHORIORETINAL ANASTOMOSIS CREATION IN CENTRAL RETINAL VEIN OCCLUSION AND SUCCESS RATE WITH A NEW PHOTOCOAGULATOR SYSTEM.Retina2016
26848880Local Modulation of Retinal Vein Tone.Invest Ophthalmol Vis Sci2016
26920098The Effect of Postoperative Face-Down Positioning and of Long- versus Short-Acting Gas in Macular Hole Surgery: Results of a Registry-Based Study.Ophthalmology2016
  • 1 - 50 of 160

Recommended Authors

Department of Ophthalmology at NYU Grossman School of Medicine
Career Start Year 2015
Number of shared co-authors 2
Universidade Federal de Sao Paulo
Career Start Year 2006
Number of shared co-authors 0
University of Washington
Career Start Year 2005
Number of shared co-authors 2
New York University School of Medicine, New York University Langone Health
Career Start Year 2004
Number of shared co-authors 4
University of California san francisco
Career Start Year 2002
Number of shared co-authors 2
Cleveland Clinic Martin Hospitals, Cleveland Clinic Florida
Career Start Year 2000
Number of shared co-authors 8
Moorfields Eye Hospital Dubai.
Career Start Year 1999
Number of shared co-authors 40
Royal Victoria Infirmary
Career Start Year 1999
Number of shared co-authors 7
Moorfields Eye Hospital NHS Foundation Trust
Career Start Year 1998
Number of shared co-authors 7
University of California davis
Career Start Year 1998
Number of shared co-authors 1
Royal Marsden NHS Foundation Trust
Career Start Year 1997
Number of shared co-authors 21
Leeds Teaching Hospitals NHS Trust
Career Start Year 1995
Number of shared co-authors 18
Sandwell & West Birmingham NHS Trust
Career Start Year 1995
Number of shared co-authors 3
Medical College of Wisconsin
Career Start Year 1994
Number of shared co-authors 4
Newcastle Hospitals NHS Foundation Trust
Career Start Year 1993
Number of shared co-authors 9
Mayo Clinic
Career Start Year 1993
Number of shared co-authors 4
Bradford Teaching Hospitals NHS Foundation Trust
Career Start Year 1992
Number of shared co-authors 5
Wills Eye Hospital/Mid Atlantic Retina
Career Start Year 1992
Number of shared co-authors 19
Harvard Medical School
Career Start Year 1992
Number of shared co-authors 0
Harvard Medical School
Career Start Year 1989
Number of shared co-authors 16
Mayo Clinic
Career Start Year 1988
Number of shared co-authors 3
From the Bascom Palmer Eye Institute, University of Miami Miller School of Medicine
Career Start Year 1986
Number of shared co-authors 4
University of Illinois at Chicago
Career Start Year 1986
Number of shared co-authors 6
University of Alabama Callahan Eye Hospital and Clinics
Career Start Year 1986
Number of shared co-authors 1
University of Wisconsin, Wisconsin EyeKor Inc.
Career Start Year 1981
Number of shared co-authors 13
Wilmer Eye Institute, Johns Hopkins University School of Medicine
Career Start Year 1979
Number of shared co-authors 12
University of Pittsburgh
Career Start Year 1977
Number of shared co-authors 2
Tufts Medical Center
Career Start Year 1975
Number of shared co-authors 1
Feinberg School of Medicine, Northwestern University
Career Start Year 1970
Number of shared co-authors 5
Kaiser Permanente San Francisco Medical Center
Career Start Year 1965
Number of shared co-authors 2

Collaborators

Lions Eye Institute
Co-authored papers 35
The University of Sydney Save Sight Institute
Co-authored papers 33
University Hospital Zurich and University of Zurich
Co-authored papers 19
Royal Victorian Eye and Ear Hospital, the University of Melbourne
Co-authored papers 16
Royal Perth Hospital
Co-authored papers 13
Lions Eye Institute
Co-authored papers 12
Lions Eye Institute, University of Western Australia
Co-authored papers 10
The Brady Urological Institute, The Johns Hopkins School of Medicine
Co-authored papers 10
The University of Sydney Save Sight Institute
Co-authored papers 10
The University of Sydney Save Sight Institute
Co-authored papers 9
Tsinghua University
Co-authored papers 6
The University of Western Australia, Australia Lions Eye Institute
Co-authored papers 3
Menzies Institute for Medical Research, University of Tasmania
Co-authored papers 3
Flinders Medical Centre, Flinders University
Co-authored papers 2
Simon Fraser University
Co-authored papers 2
University of Paris Est-Creteil
Co-authored papers 2
Queensland Eye Institute
Co-authored papers 2
University of Bonn
Co-authored papers 2
Hospital Clinic of Barcelona, University of Barcelona
Co-authored papers 2
Northwestern University
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Columbia University
Co-authored papers 1
Institute of Molecular and Clinical Ophthalmology Basel
Co-authored papers 1
University Hospital Montpellier
Co-authored papers 1
Mount Sinai School of Medicine
Co-authored papers 1
Co-authored papers 1
Center for Precision Medicine Research, Marshfield Clinic Research Institute
Co-authored papers 1
Boston University Chobanian & Avedisian School of Medicine
Co-authored papers 1
Center for Inherited Disease Research, Johns Hopkins School of Medicine
Co-authored papers 1